iRGD-modified lipid–polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability

Isoliquiritigenin (ISL), a natural anti-breast cancer dietary compound, has poor delivery characteristics and low bioavailability. In order to promote the therapeutic outcome of ISL, a tumor-targeting lipid–polymer hybrid nanoparticle (NP) system modified by tumor-homing iRGD peptides has been devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Fei, Zhang, Jinming, Fu, Chaomei, Xie, Xiaoming, Peng, Fu, You, Jieshu, Tang, Hailin, Wang, Zhiyu, Li, Peng, Chen, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459978/
https://www.ncbi.nlm.nih.gov/pubmed/28615942
http://dx.doi.org/10.2147/IJN.S134148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459978/
https://www.ncbi.nlm.nih.gov/pubmed/28615942
http://dx.doi.org/10.2147/IJN.S134148

Ejemplares similares